Cargando…

Target specific serologic analysis of COVID-19 convalescent plasma

This study compared the performance of four serology assays for Coronavirus Disease 2019 (COVID-19) and investigated whether COVID-19 disease history correlates with assay performance. Samples were tested at Northshore using the Elecsys Anti-SARS-CoV-2 (Roche Diagnostics), Access SARS-CoV-2 IgG anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikegami, Sachie, Benirschke, Robert C., Fakhrai-Rad, Hossein, Motamedi, Mohammad H., Hockett, Rick, David, Sean, Lee, Hong Kee, Kang, Jason, Gniadek, Thomas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081213/ https://www.ncbi.nlm.nih.gov/pubmed/33909632 http://dx.doi.org/10.1371/journal.pone.0249938

Ejemplares similares

Rapidly Establishing a Hospital-Based Convalescent Plasma Collection Center With the Alyx Apheresis Collection Device
por: Klein, Tovah, et al.
Publicado: (2021)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma
por: Sullivan, David, et al.
Publicado: (2023)

SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma
por: Dulipsingh, Latha, et al.
Publicado: (2020)

Utilization of genetic data can improve the prediction of type 2 diabetes incidence in a Swedish cohort
por: Zarkoob, Hadi, et al.
Publicado: (2017)

Convalescent plasma in patients hospitalised with COVID-19
por: Liu, Sean T H, et al.
Publicado: (2021)

The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection
por: Fazeli, Alieh, et al.
Publicado: (2022)

The effect of convalescent plasma on the treatment of COVID-19 patients in Ardabil, Iran
por: Iranijam, Effat, et al.
Publicado: (2022)

Earlier the better: convalescent plasma
por: Tobian, Aaron A.R., et al.
Publicado: (2020)

The resurgence of convalescent plasma therapy
por: The Lancet Haematology
Publicado: (2020)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern
por: Li, Maggie, et al.
Publicado: (2022)

Early Outpatient Treatment for Covid-19 with Convalescent Plasma
por: Sullivan, David J., et al.
Publicado: (2022)

Analysis of Clinical Course and Vaccination Influence on Serological Response in COVID-19 Convalescents
por: Adamczuk, Justyna, et al.
Publicado: (2022)

Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion
por: Farhat, Ryan M., et al.
Publicado: (2020)

Convalescent plasma trial shows no benefit
por: Brown, Matthew
Publicado: (2020)

Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021)

Serosurveys and convalescent plasma in COVID-19
por: Pérez-Cameo, Cristina, et al.
Publicado: (2020)

COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020)

Convalescent plasma in outpatients with COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Convalescent plasma: Alternative or promising therapy?
por: Mina, Fahmida Begum, et al.
Publicado: (2021)

Plasma exchange followed by convalescent plasma transfusion in COVID-19 patients
por: Roshandel, Elham, et al.
Publicado: (2021)

Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern
por: Li, Maggie, et al.
Publicado: (2022)

Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients
por: Muecksch, Frauke, et al.
Publicado: (2020)

Timing of convalescent plasma therapy-tips from curing a 100-year-old COVID-19 patient using convalescent plasma treatment: A case report
por: Liu, Bo, et al.
Publicado: (2021)

Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma
por: Tonn, Torsten, et al.
Publicado: (2020)

Convalescent Plasma Therapy for Coronavirus Disease 2019
por: Choi, Jun Yong
Publicado: (2020)

The true historical origin of convalescent plasma therapy
por: Marson, Piero, et al.
Publicado: (2020)

Efficacy of convalescent plasma for the treatment of severe influenza
por: Xu, Zhiheng, et al.
Publicado: (2020)

Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)

Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)

Donating convalescent plasma for COVID-19 patients
por: Black, Emily
Publicado: (2020)

Challenges of Convalescent Plasma Therapy on COVID-19
por: Zhao, Qian, et al.
Publicado: (2020)

Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini, Massimo, et al.
Publicado: (2021)

Functional Antibodies in COVID-19 Convalescent Plasma
por: Herman, Jonathan D., et al.
Publicado: (2021)

Convalescent plasma in the management of COVID-19 pneumonia
por: Elbadawi, Ayman, et al.
Publicado: (2021)

How Safe Is COVID-19 Convalescent Plasma?
por: Franchini, Massimo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_233badvitoiviclvql091mjm2n